(0.06%) 5 472.47 points
(0.06%) 39 135 points
(0.38%) 17 786 points
(-0.04%) $80.80
(-3.66%) $2.66
(-0.77%) $2 312.80
(0.21%) $28.93
(3.61%) $1 022.00
(0.29%) $0.936
(0.71%) $10.68
(0.45%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders...
Stats | |
---|---|
今日成交量 | 37 201 |
平均成交量 | 187 146 |
市值 | 40.40M |
EPS | $-0.290 ( Q1 | 2024-03-31 ) |
下一个收益日期 | ( $-0.290 ) 2024-08-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-3.32 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00500 (0.32%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-11 | Rodgers Richard J | Buy | 41 143 | Common Stock |
2024-06-11 | Rodgers Richard J | Buy | 35 181 | Stock Option (Right to Buy) |
2024-06-11 | Pepose Jay | Buy | 41 143 | Common Stock |
2024-06-11 | Pepose Jay | Buy | 35 181 | Stock Option (Right to Buy) |
2024-06-11 | Manuso James S J | Buy | 41 143 | Common Stock |
INSIDER POWER |
---|
96.19 |
Last 94 transactions |
Buy: 4 001 388 | Sell: 115 125 |
音量 相关性
Ocuphire Pharma, Inc. 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Ocuphire Pharma, Inc. 相关性 - 货币/商品
Ocuphire Pharma, Inc. 财务报表
Annual | 2023 |
营收: | $19.05M |
毛利润: | $19.04M (99.97 %) |
EPS: | $-0.460 |
FY | 2023 |
营收: | $19.05M |
毛利润: | $19.04M (99.97 %) |
EPS: | $-0.460 |
FY | 2022 |
营收: | $39.85M |
毛利润: | $39.85M (99.99 %) |
EPS: | $0.900 |
FY | 2021 |
营收: | $589 000 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-3.82 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Ocuphire Pharma, Inc.
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induced mydriasis, as well as that has completed Phase 2 VEGA-1 trial for presbyopia. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. Ocuphire Pharma, Inc. is headquartered in Farmington Hills, Michigan.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。